Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
BioMarin, following sluggish sales, to offload hemophilia gene therapy | BioP...
https://www.biopharmadive.com/news/biomarin-divest-roctavian-hemophilia-gene-therapy/803931
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
» Social Media: Pharma Industry Considers Patient Engagement a MustHealth in...
https://healthin30.com/2012/02/social-media-pharma-industry-considers-patient-engagement-a-must
healthin30.com
|
37 | 3 | 72 |
Barbara Ficarra Quoted in PharmaVoice
http://www.pharmavoice.com/archives/article.esiml?id=2247
DOFOLLOW
|
|
Deep Learning Network Predicts Adverse Cardiac Events | TechTarget
https://www.techtarget.com/healthtechanalytics/news/366591180/Deep-Learning-Network-Predicts-Adverse-Cardiac-Events
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
KLAS: Ambient AI tool delivers measurable ROI for health systems | TechTarget
https://www.techtarget.com/healthtechanalytics/news/366637584/KLAS-Ambient-AI-tool-delivers-measurable-ROI-for-health-systems
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
Novo keeps price in line with FDA approval of second obesity shot | BioPharma...
https://www.biopharmadive.com/news/novo-new-obesity-drug-approved-wegovy/601371
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Pfizer's neuroscience spinout scores in schizophrenia | BioPharma Dive
https://www.biopharmadive.com/news/cerevel-schizophrenia-study-data/602562?utm_campaign=Issue: 2021-06-29 BioPharma Dive [issue:35144]&utm_medium=email&utm_source=Sailthru&utm_term=BioPharma Dive
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Artificial intelligence in healthcare | Resources and Information from TechTa...
https://www.techtarget.com/healthtechanalytics/resources/Artificial-intelligence-in-healthcare/page/15
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
Biotech startup funding dried up in second quarter, HSBC finds | BioPharma Dive
https://www.biopharmadive.com/news/biotech-venture-capital-funding-h1-2025-hsbc/753283?mkt_tok=NDkwLUVIWi05OTkAAAGb8FH4UwAyG4VfGD_CEPZTZ2Fzx9IlGJGpuRAgSkyiJtkhxf8KhDkjl3Miql1o4sfjiQ3Q-NVeijlJPCBiaZ8RYUfl4jbii7ft0gxtnd3fuRrObg
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Sickle cell pipeline narrows as gene therapy developers rethink research plan...
https://www.biopharmadive.com/news/intellia-graphite-sangamo-sickle-cell-gene-therapy-discontinue/643400
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Sofinnova secures €1.2B for new biotech investments | BioPharma Dive
https://www.biopharmadive.com/news/sofinnova-raises-funds-biotech-venture-capital/741518
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Remdesivir, chloroquine move to forefront as White House tries to speed coron...
https://www.biopharmadive.com/news/trump-fda-chloroquine-remdesivir-coronavirus-covid19/574505
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Biosimilars | BioPharma Dive
https://www.biopharmadive.com/trendline/biosimilars/47?preview_no_gate=trendline_47
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Predictive Model Illustrates Transmissibility of COVID-19 | TechTarget
https://www.techtarget.com/healthtechanalytics/news/366591027/Predictive-Model-Illustrates-Transmissibility-of-COVID-19
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
The patient retention crisis is happening before enrollment even begins | Bio...
https://www.biopharmadive.com/spons/the-patient-retention-crisis-is-happening-before-enrollment-even-begins/809568
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Memorial Sloan Kettering scandal raises questions for pharma's biggest corpor...
https://www.biopharmadive.com/news/memorial-sloan-kettering-scandal-raises-questions-for-pharmas-biggest-corp/540750
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Aardvark prices $94M IPO to fund Prader-Willi, obesity drug work | BioPharma ...
https://www.biopharmadive.com/news/aardvark-biotech-ipo-prader-willi-obesity/739745
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Mylan's generic Copaxone wins in court, but market barriers remain | BioPharm...
https://www.biopharmadive.com/news/mylans-generic-copaxone-wins-in-court-but-market-barriers-remain/539666
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Newsroom | Novavax
https://www.novavax.com/newsroom
novavax.com
|
67 | 84 | 32 |
Read the article
https://www.pharmavoice.com/news/novavax-vaccine-rfkjr-hhs-fda-pfizer/810662
DOFOLLOW
|
|
Facet Product Development Champion Acknowledged for Regulatory Expertise
https://www.prweb.com/releases/facet-product-development-champion-acknowledged-for-regulatory-expertise-897341552.html
prweb.com
|
84 | 4,782 | 14 |
here.
http://www.pharmavoice.com/current-issue?issue=224
NOFOLLOW
|
|
Lilly’s Zepbound beats Novo’s Wegovy in high-stakes obesity drug trial | BioP...
https://www.biopharmadive.com/news/lilly-zepbound-novo-wegovy-obesity-drug-weight-loss-trial/734227
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
New CRISPR, gene therapy results strengthen potential for treatment of blood ...
https://www.biopharmadive.com/news/crispr-vertex-bluebird-sickle-cell-thalassemia-study-update/579692
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Oxford Biomedica confirms takeover talks with biotech investor EQT | BioPharm...
https://www.biopharmadive.com/news/oxford-biomedica-eqt-offer-acquire-cell-gene-therapy/809705
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure | Bi...
https://www.biopharmadive.com/news/vinay-prasad-cber-return-fda-vaccines-gene-therapy/757263
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
FDA flags rare side effect in new warning on J&J's coronavirus vaccine | BioP...
https://www.biopharmadive.com/news/fda-warning-johnson-johnson-coronavirus-vaccine-guillain-barre/603186
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
News | CluePoints
https://cluepoints.com/resources/insights/news?e-page-667a09e=5&e-page-778e795=4&e-page-be75213=2
cluepoints.com
|
14 | 16 | 60 |
Read
https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-ai-drug-rd-development/809144
DOFOLLOW
|
|
Apples to apples: Stelara biosimilars and the fight for market share | BioPha...
https://www.biopharmadive.com/spons/apples-to-apples-stelara-biosimilars-and-the-fight-for-market-share/753098
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
GE to spin off healthcare unit in latest restructuring | BioPharma Dive
https://www.biopharmadive.com/news/ge-to-spin-off-healthcare-unit-in-latest-restructuring/526661
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
GSK ups US investment with $30B spending plan | BioPharma Dive
https://www.biopharmadive.com/news/gsk-us-manufacturing-investment-30-billion-pennsylvania/760366
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
A closer look at the Ebola drug that's become the top hope for a coronavirus ...
https://www.biopharmadive.com/news/coronavirus-remdesivir-gilead-antiviral-drug-covid-19/573261?utm_campaign=Issue: 2020-03-05 BioPharma Dive [issue:26032]&utm_medium=email&utm_source=Sailthru&utm_term=BioPharma Dive
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Verdiva starts up with $411M and a portfolio of obesity drugs from China | Bi...
https://www.biopharmadive.com/news/verdiva-obesity-biotech-startup-launch-sciwind-china/736880
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
German Merck finally gets yes for MS drug Mavenclad | BioPharma Dive
https://www.biopharmadive.com/news/merck-kgaa-mavenclad-fda-approval-multiple-sclerosis/551750
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Research project Archives - Monsenso
https://www.monsenso.com/tag/research-project
monsenso.com
|
12 | 9 | 150 |
differentiate their product from similar drugs for coverage
https://www.pharmavoice.com/article/pro-strategy
DOFOLLOW
|
|
Reclaiming registries for integrated evidence generation throughout the produ...
https://www.biopharmadive.com/spons/reclaiming-registries-for-integrated-evidence-generation-throughout-the-pro/692902
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Novartis taps Cryoport for CAR-T logistics support | BioPharma Dive
https://www.biopharmadive.com/news/novartis-cryoport-car-t-logistics-shipping-cryopreservation/448060
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
How AI Agents Redefine Hiring Across Industries | Hyreo
https://hyreo.com/ai-agents-for-hiring-industry-wise-analysis
hyreo.com
|
52 | 6 | 105 |
PharmaVoice
https://www.pharmavoice.com/news/ai-expertise-pharma-hiring-need-eli-lilly/749194
DOFOLLOW
|
|
Deep Learning Accurately Predicts Antihypertensive Treatment Success | TechTa...
https://www.techtarget.com/healthtechanalytics/news/366590117/Deep-Learning-Accurately-Predicts-Antihypertensive-Treatment-Success
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
Arena, completing its turnaround, sells to Pfizer for nearly $7 billion | Bio...
https://www.biopharmadive.com/news/pfizer-acquires-arena-pharmaceuticals-inflammation-drugs/611383
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
pivotal trials Archives - Monsenso
https://www.monsenso.com/tag/pivotal-trials
monsenso.com
|
12 | 9 | 150 |
differentiate their product from similar drugs for coverage
https://www.pharmavoice.com/article/pro-strategy
DOFOLLOW
|
|
Psychiatry drugs finally have pharma’s attention. Can they keep it? | BioPhar...
https://www.biopharmadive.com/news/psychiatry-drug-development-pharma-neuroscience-karuna/712353
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Real-world data: A health equity lens for research | BioPharma Dive
https://www.biopharmadive.com/spons/real-world-data-a-health-equity-lens-for-research/624983
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Collaboration key to using data standards for value-based care | TechTarget
https://www.techtarget.com/healthtechanalytics/feature/Collaboration-key-to-using-data-standards-for-value-based-care
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
PharmaVOICE speaks to our newly appointed Chief Precision Officer, Susanne Mu...
https://www.diaceutics.com/articles/pharmavoice-speaks-to-our-newly-appointed-chief-precision-officer-susanne-munksted-for-the-latest-podcast-in-their-woman-of-the-week-series
diaceutics.com
|
61 | 14 | 92 |
Click here to view the full article
https://www.pharmavoice.com/wow-podcasts/wow-susanne-munksted
DOFOLLOW
|
|
News | CluePoints
https://cluepoints.com/resources/insights/news?e-page-667a09e=5&e-page-778e795=5&e-page-be75213=4
cluepoints.com
|
14 | 16 | 60 |
Read
https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-ai-drug-rd-development/809144
DOFOLLOW
|
|
News | CluePoints
https://cluepoints.com/resources/insights/news?e-page-667a09e=5&e-page-778e795=5&e-page-be75213=4
cluepoints.com
|
14 | 16 | 60 |
Read
https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-ai-drug-rd-development/809144
DOFOLLOW
|
|
Mass General Hits Health Equality via Demographic Data Collection | TechTarget
https://www.techtarget.com/healthtechanalytics/news/366591166/Mass-General-Hits-Health-Equality-via-Demographic-Data-Collection
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
Arvinas reboots, cuts more staff; Porges joins Lazard | BioPharma Dive
https://www.biopharmadive.com/news/arvinas-pfizer-out-license-porges-lazard-vertex-casgevy-italy/760567
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
New Project Puts an Actuarial Eye on Big Data, Healthcare Costs | TechTarget
https://www.techtarget.com/healthtechanalytics/answer/New-Project-Puts-an-Actuarial-Eye-on-Big-Data-Healthcare-Costs
techtarget.com
|
85 | 7,023 | 3,598 |
The most valuable up-and-coming GLP-1s
https://www.pharmavoice.com/news/big-pharmas-most-valuable-glp-1-lilly-novo-amgen/811416
DOFOLLOW
|
|
Global regenerative drugs market projected to reach $195.89 billion by 2032 w...
https://noah-news.com/global-regenerative-drugs-market-projected-to-reach-195-89-billion-by-2032-with-rapid-growth
noah-news.com
|
12 | 10 | 619 |
https://www.pharmavoice.com/news/2022-advanced-technologies-in-regenerative-medicine/
https://www.pharmavoice.com/news/2022-advanced-technologies-in-regenerative-medicine
DOFOLLOW
|
|
J&J secures FDA OK for immune drug touted as future blockbuster | BioPharma Dive
https://www.biopharmadive.com/news/johnson-johnson-nipocalimab-fda-approval-imaavy-myasthenia-gravis/746709
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
|
Takeda stakes more than $11B on cancer drugs from China | BioPharma Dive
https://www.biopharmadive.com/news/takeda-innovent-cancer-drug-licensing-deal-china/803454
biopharmadive.com
|
76 | 355 | 578 |
PharmaVoice
https://www.pharmavoice.com/
DOFOLLOW
|
Frequently Asked Questions
How many backlinks does pharmavoice.com have?
The backlinks page for pharmavoice.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on pharmavoice.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to pharmavoice.com dofollow or nofollow?
Backlinks to pharmavoice.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.